Caricamento...
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
In December 2019, a novel SARS-CoV-2 coronavirus emerged, causing an outbreak of life-threatening pneumonia in the Hubei province, China, and has now spread worldwide, causing a pandemic. The urgent need to control the disease, combined with the lack of specific and effective treatment modalities, c...
Salvato in:
| Pubblicato in: | Drug Resist Updat |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Published by Elsevier Ltd.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362818/ https://ncbi.nlm.nih.gov/pubmed/32717568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2020.100719 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|